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Abstract
The diagnosis of prosthetic joint infection (PJI) in the routine
microbiology laboratory is labour-intensive, but semi-automated
methods may be appropriate. We prospectively compared four
microbiological culture methods on samples taken at prosthetic
joint revision surgery. Automated BACTEC blood culture bot-
tles and cooked meat enrichment broth were the most sensitive
methods (87% and 83%, respectively, as compared with fastidi-
ous anaerobic broth (57%) and direct plates (39%)); all were
highly speciﬁc (97–100%). To our knowledge, this is the ﬁrst
prospective study aimed at comparing culture methods in rou-
tine use in UK clinical laboratories for the diagnosis of PJI.
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Microbiological diagnosis of prosthetic joint infection (PJI) is
complex and laborious [1–5]. Automated blood culture bot-
tles have been used for synovial ﬂuid [6,7] but not for tissue
suspensions.
This study was designed to compare the sensitivity and
speciﬁcity for PJI of the following four microbiological culture
media: direct plates; the enrichment medium of our local
standard operating procedure (Robertson’s cooked meat
broth (CM)); an alternative enrichment medium (fastidious
anaerobic broth (FA) [8]); and automated BACTEC blood
culture bottles.
The study was performed at the Oxford Radcliffe Hospital
(ORH) NHS Trust Microbiology laboratory, which serves
both the ORH Trust and the Nufﬁeld Orthopaedic Centre.
All joint revisions performed between December 2006 and
September 2007 were included prospectively.
Surgeons collected multiple intra-operative specimens
according to an established protocol. These were trans-
ported immediately to the laboratory for processing [9].
Gram stains were not performed. Previous experience had
shown these to be poorly sensitive for PJI [9].
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Microbiological analysis was carried out by Biomedical
Scientiﬁc Ofﬁcers in the Class 2 safety cabinet, using aseptic
technique. Sterile glass (Ballotini) beads [8] and 5 mL of sterile
saline were added, and vigorous shaking was used to disrupt
tissue and release bacteria. One-millilitre aliquots were inocu-
lated into: 5 mL of CM, 5 mL of FA, a BACTEC Standard
Anaerobic/F blood culture bottle, and a BACTEC Plus Aero-
bic/F blood culture bottle (Becton Dickinson, Oxford, UK).
CM and FA were incubated at 37C in air; BACTEC blood
culture bottles were placed on the BACTEC 960 platform
(Becton Dickinson) for 5 days. A further 1 mL was divided
into 0.25-mL aliquots, which were inoculated onto a choco-
late agar plate incubated at 37C in CO2, a blood agar plate
incubated at 37C in CO2, a blood agar plate incubated at
37C anaerobically, and a further blood agar plate with a met-
ronidazole disk continuously incubated anaerobically at 37C
for 5 days. All other plates were examined daily for 5 days.
CM and FA were examined daily, and terminally subcultured
at 5 days or if turbid, onto chocolate agar (at 37C in CO2
for 48 h) and blood agar (at 37C anaerobically for 48 h).
BACTEC bottles were subcultured if they ﬂagged positive.
Organisms were identiﬁed and antibiotic sensitivities were
determined by the Stokes method [10]. Organisms of the
same species were deemed to be indistinguishable if they
had the same colony morphology, the same biochemical fea-
tures on API testing (bioMerieuz Vitek, Hazelwood, Ml,
USA), and an identical extended antibiogram.
Multiple specimens were taken at operation for histology,
and reported by the same osteoarticular histopathologist as
‘infected’, ‘indeterminate’, or ‘not infected’, on the basis of
the degree of polymorphonuclear leukocyte inﬁltration
[9,11]. The histopathologist was not aware of the microbiol-
ogy results. Data were analysed with STATA version 10
(Stata Corp., College Station, TX, USA).
Eight hundred and forty-nine separate specimens were
received from a total of 178 elective joint revision cases.
Thirty-seven cases were excluded: ten were not sent for his-
tological examination, ﬁve had inﬂammatory arthropathies,
and 22 had indeterminate histology results. Of the remaining
141 cases, 23 (16%) were classiﬁed as infected on histological
examination. Ten (9.5%) of 115 hip revisions and 13 (50%) of
26 knee revisions were infected. Patients ranged in age from
21 to 94 years (mean: 68 years). Eighty-nine (63%) were
female. The mean number of specimens received per patient
was 4.9 (mode 5, range 3–8). Gram-positive organisms were
isolated from 19 (90%) of culture-positive infected cases
(Table 1).
BACTEC and CM were both signiﬁcantly more sensitive
than FA and direct plates according to a chi-squared test
(p 0.007, p 0.016; Table 2). There was no signiﬁcant differ-
ence in sensitivity between BACTEC and CM (p 0.74).
We conducted secondary analyses to examine how sensi-
tive our results were to the use of different criteria for
‘true-positive’ or ‘test-positive’ status: (i) taking either posi-
tive histology or ‡2 positive microbiology results as indica-
tive of a true positive; and then (ii) including ‡1 virulent
organism (e.g. Staphylococcus aureus or Streptococcus pyogenes)
in the deﬁnition of a positive microbiological result. How-
ever, these re-analyses only changed one or two categoriza-
tions, and so did not signiﬁcantly change the results (data
not shown).
Enrichment culture broths were signiﬁcantly more sensi-
tive than the direct plates used alone. This may reﬂect the
TABLE 1. Number of patients with both positive histology
results and ‡2 specimens positive on culture for each culture med-
ium
Culture media
Microorganism isolated
Direct
plates
Cooked
meat
broth
Fastidious
anaerobic
broth
BACTEC
blood
culture
bottles
Gram-positive cocci
CoNS 3 8 5 7
CoNS-mixeda 0 2 1 2
Staphylococcus aureus 4 4 3 4
S. aureus + CoNS 0 1 1 1
Enterococcus faecalis 0 1 1 1
Streptococcus spp.b 2 2 1 3
Gram-negative rods
Klebsiella pneumoniae 0 1 1 1
Escherichia coli + CoNS 0 0 0 1
Total number of patients with
positive microbiology and histology results
9 19 13 20
CoNS, coagulase-negative Staphylococcus.
aCoNS-mixed: two strains of CoNS as determined by differences in antibiotic
susceptibility pattern. Where there were more than two differences in suscepti-
bility to antibiotics, they were counted as separate strains. They were not iden-
tiﬁed further.
bStreptococcus spp.: includes one group B that was detected by all four media,
and two viridans group streptococci.
TABLE 2. Sensitivity and speciﬁcity of each culture method for diagnosis of prosthetic joint infection
Culture media
Sensitivity/speciﬁcity Direct plates Cooked meat broth Fastidious anaerobic broth BACTEC blood culture bottles
Sensitivity, % (95% CI) 39 (18–61) 83 (66–99) 57 (35–78) 87 (72–100)
Speciﬁcity, % (95% CI) 100 (97–100) 97 (95–100) 100 (97–100) 98 (96–100)
CI, conﬁdence interval.
A joint was deemed to be infected if ‡2 specimens per patient were positive on culture. This was compared to a histology criterion standard.
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culture requirements for bioﬁlm-associated organisms in PJI
[1,3,4,7,9,12].
BACTEC had comparable sensitivity to CM, but the
power of this comparison is limited by the low number of
true positives (n = 23). Even with optimal enrichment media,
traditional culture for diagnosis of PJI remains relatively
insensitive. This may be improved by sonication of implants
prior to culture, although this is not always available in rou-
tine laboratories, and may reduce speciﬁcity [13]. BACTEC
Paeds Plus/F bottles have a smaller optimal volume of inocu-
lum, and may warrant comparison with the BACTEC bottles
used in this study, as tissue samples may be small, with
potentially low numbers of organisms [6,14].
All tests were highly speciﬁc (Table 2), including direct
plates and broths, probably because the multiple sampling
protocol effectively distinguishes contaminants from true
infections.
BACTEC had the shortest time to positivity of the three
enrichment culture broths. This difference may be attribut-
able to the late pick-up of macroscopic changes in the tur-
bidity of CM as compared with the automated system of
ﬂagging positive cultures in BACTEC. Direct plates had the
shortest mean time to positivity overall, at 1.8 days, but
were much less sensitive than BACTEC and CM.
We incubated two BACTEC bottles per specimen: of the
123 samples from true-positive patients, 84 (68%) were posi-
tive in both bottles, 29 (24%) were negative in both bottles,
and ten (8%) were positive in only one bottle. We cannot
determine whether these ten resulted from stochastic varia-
tion (that is, inocula were close to the limit of detection) or
from preferential growth in one of the two culture conditions.
However, the use of both bottles would have been critical to
the overall determination of positivity in two of 23 patients.
To our knowledge, this is the ﬁrst study to prospectively
evaluate four different culture media used in the diagnosis of
PJI. Extending the use of the BACTEC system for the culture
of these specimens is attractive, given that it is a fully auto-
mated closed system with continuous monitoring.
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